Your Messages Inbox
Your Article Summary
See Latest ArticlesMediGene successfully completes patient recruitment into EndoTAG(TM)-1 Phase II breast cancer trial
MediGene, 10/12/09
MediGene AG has successfully completed patient recruitment into its randomized Phase II trial of EndoTAG(TM)–1 for the treatment of triple receptor–negative breast cancer. Results will be available as scheduled in the first six months of 2010. This multinational clinical trial is being conduced across more than 20 centres in Europe and India.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer HealthCare Pharmaceuticals Inc. Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Bayer HealthCare Pharmaceuticals, 12/07/09
Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid
Journal of Clinical Microbiology, 12/03/09
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects
b3c newswire, 12/07/09
Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN at 51st ASH Annual Meeting
Allos Therapeutics, 12/07/09
Nplate Data From MDS Studies Presented at ASH
Amgen, 12/07/09
Article Search
Sponsor